Recent Advances in the Application of Biomaterials in Drug Delivery and Regenerative Medicines
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 309
Special Issue Editors
Interests: drug and peptide delivery; biomaterials biotechnology; chemical engineering
Interests: oral drug delivery; nanoparticles; silicon and polymeric; antioxidant; anti-inflammatory; antibacterial and anticancer; extraction; metal chelating
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Biomaterial advances have allowed significant progress in biology and medicine, with biomaterials becoming increasingly important for drug delivery, tissue engineering, and new clinical treatments. Each class of biomaterials, from natural and synthetic polymers to bioactive ceramics and composites, has particular properties that are suitable for a particular application. It is essential, however, that materials be designed that support and guide cells during healing and remodeling processes in regenerative medicine. A number of advanced tissue engineering systems work in conjunction with bioactive agents to enhance tissue regeneration by modulating the cellular environment. Bioactive agents include, for example, small molecules, bioactive ions, genes, cells, and growth factors applied either singly or simultaneously to a target. In many cases, bioactive agents must act intracellularly at the molecular level due to their sensitivity to the surrounding environment. It is therefore required to provide a suitable carrier, such as hydrogels, bioceramics, electrospun fibers, nano/microparticles, or genetically modified cells, in order for these agents to be effective. It is also important to emphasize that such local or site-specific smart drug delivery systems are highly successful because they combine active agents, cells, biomaterials, and nanotechnologies efficiently.
Here, we invite all researchers to contribute to this Special Issue, which will collect both research and review articles devoted to various aspects covering recent progress and ongoing developments in the context of regenerative medicine and drug delivery approaches.
Dr. Seyed Ebrahim Alavi
Dr. Aun Raza
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery
- biomaterials
- regenerative medicine
- tissue engineering
